TruLite Health is a technology company.
TruLite Health has raised $7.0M across 1 funding round.
TruLite Health has raised $7.0M in total across 1 funding round.
TruLite Health has raised $7.0M in total across 1 funding round.
TruLite Health's investors include BrightCap Ventures, Gutbrain Ventures, NewFund, Osage University Partners.
TruLite Health is a Tempe, Arizona-based healthcare technology company founded in 2021 that develops Truity™, the industry's first comprehensive health equity platform designed to remediate clinical bias and deliver equitable care.[1][2][3][7] The SaaS platform integrates seamlessly into electronic health records (EHRs), analyzing patient-specific clinical, social, and behavioral data against the largest proprietary health equity knowledge base to provide actionable, point-of-care interventions for clinicians, care teams, and patients.[1][3][4][5] It serves healthcare providers, hospitals, and health systems aiming to address disparities in diverse populations—such as those driven by race, gender, zip code, or orientation—ultimately improving outcomes, reducing costs (tackling the $320B U.S. annual burden), boosting reimbursements, and enhancing brand equity.[2][3][5][7]
The company targets systemic issues like institutionalized racism in medicine, exemplified by higher Black maternal mortality rates, by suggesting tailored actions like early screenings, dosage adjustments, educational resources, and virtual health equity coaching.[2][4][5] With $11.09M raised (including a $7M Series A led by Osage Venture Partners nine months ago), TruLite is in Series A stage and has secured key partnerships, including a January 2024 know-how agreement with Mayo Clinic Arizona for deployment, feedback, and enhancements, plus collaboration with Morehouse School of Medicine.[1][5][8]
TruLite Health was founded in 2021 by Alan Roga, MD, an ER physician and seasoned healthtech entrepreneur who serves as CEO and co-founder, driven by worsening global health disparities beyond socioeconomics—like lack of diversity in clinical trials and institutionalized biases costing the U.S. $320B yearly per Deloitte.[2][4][6] Roga and his team studied healthcare tools, practitioners, and research, identifying clinical bias as a core issue, and built Truity™ as a clinically integrated SaaS tool to make health equity actionable in workflows.[1][2][4]
Early traction came swiftly: the company entered the commercial market with Truity, attracting significant interest that fueled a $7M Series A to expand sales and support.[1][8] Pivotal moments include the January 2024 Mayo Clinic Arizona agreement for real-world deployment and workflow optimization, alongside Morehouse School of Medicine for patient coaching—validating the platform amid rising regulatory pressures from bodies like CMS, Joint Commission, and FDA.[2][5]
TruLite rides the health equity and AI-driven precision medicine wave, addressing escalating disparities amid regulatory mandates from CMS, Joint Commission, and FDA that prioritize bias reduction and value-based care.[1][5] Timing is ideal as U.S. healthcare inequities widen—costing $320B annually—and global issues mirror in Western nations like the UK and Germany, creating massive demand for integrated solutions.[2][4] Market forces favoring TruLite include AI adoption in EHRs, payer shifts to outcomes-based reimbursements, and post-pandemic focus on social determinants of health (SDOH), positioning it to influence ecosystems by enabling providers to deliver equitable, cost-effective care at scale.[3][5][7]
The company's Mayo Clinic collaboration amplifies credibility, potentially standardizing bias remediation nationwide, while its SDOH focus aligns with broader tech trends like personalized nudges and community interventions.[2][5]
TruLite Health is poised for rapid scaling post-Series A, with Truity's commercial rollout accelerating via Mayo Clinic deployment (targeting user enhancements and evaluations) and Morehouse coaching expansion—driving adoption among health systems, payers, and employers.[1][5][8] Expect growth fueled by regulatory tailwinds, AI advancements in knowledge bases, and rising health equity mandates, potentially evolving into a global standard for bias-free care amid value-based payment dominance.[4][6]
As disparities persist, TruLite's mission to transform outcomes through point-of-care equity—starting from its Tempe roots—could redefine provider workflows, much like its founders envisioned when tackling clinical bias head-on.
TruLite Health has raised $7.0M across 1 funding round. Most recently, it raised $7.0M Series A in August 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2023 | $7.0M Series A | BrightCap Ventures, Gutbrain Ventures, NewFund, Osage University Partners |